IRIDEX Corporation (IRIX)
NASDAQ: IRIX · Real-Time Price · USD
1.660
+0.020 (1.22%)
Jan 17, 2025, 4:00 PM EST - Market closed
IRIDEX Revenue
IRIDEX had revenue of $11.58M in the quarter ending September 28, 2024, a decrease of -9.88%. This brings the company's revenue in the last twelve months to $48.43M, down -11.31% year-over-year. In the year 2023, IRIDEX had annual revenue of $51.87M, down -8.96%.
Revenue (ttm)
$48.43M
Revenue Growth
-11.31%
P/S Ratio
0.56
Revenue / Employee
$436,315
Employees
111
Market Cap
27.62M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 30, 2023 | 51.87M | -5.10M | -8.96% |
| Dec 31, 2022 | 56.97M | 3.07M | 5.69% |
| Jan 1, 2022 | 53.90M | 17.56M | 48.30% |
| Jan 2, 2021 | 36.35M | -7.10M | -16.34% |
| Dec 28, 2019 | 43.45M | 847.00K | 1.99% |
| Dec 29, 2018 | Pro | Pro | Pro |
| Dec 30, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Jan 2, 2016 | Pro | Pro | Pro |
| Jan 3, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 87.70B |
| Merck & Co. | 63.17B |
| AbbVie | 55.53B |
| AstraZeneca | 51.21B |
| Novartis AG | 49.94B |
| Thermo Fisher Scientific | 42.37B |
| Abbott Laboratories | 41.22B |
IRIX News
- 4 weeks ago - Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management - GlobeNewsWire
- 2 months ago - Iridex Comments on Changing Glaucoma Reimbursement Landscape - GlobeNewsWire
- 2 months ago - IRIDEX Corporation (IRIX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024 - GlobeNewsWire
- 3 months ago - Iridex Appoints Patrick Mercer as Chief Executive Officer - GlobeNewsWire
- 5 months ago - Iridex Frustrates, But Expect A Transaction By Year-End - Seeking Alpha
- 5 months ago - IRIDEX Corporation (IRIX) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 8 months ago - IRIDEX Corporation (IRIX) Q1 2024 Earnings Call Transcript - Seeking Alpha